BU-NOT-SET

CONTACT US
Overcoming oncolytic virus obstacles with the help of a CDMO partnership
  • Biologics
oncolytic virus
Insight
Webinar: Beyond borders: Navigating global scale-up for viral-based therapies
  • Biologics
webinar
Webinar
Choosing the right container for your sterile drug product
  • Drug product
eBook: How a CDMO partner helps choose the right container for sterile drug products
eBook
Cell and virus banking in OV development and manufacturing
  • Biologics
Cell and virus banking
White paper
Overcoming technical transfer challenges in virotherapy manufacturing
  • Biologics
virotherapy
Insight
Flexibility in gene therapy: Adapting to the unique gene therapy demands
  • Biologics
gene therapy
eBook
Webinar: An optimised Plasmid DNA platform
  • Biologics
Plasmid DNA
Webinar
The future of oral solid dose formulations
  • Drug substance
  • Industry trends
oral solid dose
Insight
Trends and challenges to impact the OSD space in 2024 and beyond
  • Industry trends
OSD
Insight
Insight
  • Industry trends
Emerging trends set to impact drug development in 2024
Webinar
  • Biologics
Webinar: ATMPs in focus: Essential CMC strategies for every phase
Insight
  • Drug product
  • Industry trends
Trends set to make an impact on oral solid dose development in 2024
Insight
  • Biologics
Enhancing AAV therapy development and manufacture with a platform approach
Insight
  • Drug product
  • Industry trends
Challenges and solutions to enhancing mRNA stability with lyophilisation processes
Insight
  • Industry trends
  • Manufacturing
A well-equipped CDMO for OSD contract manufacturing
Insight
  • Analytical chemistry
  • Industry trends
Optimising efficiency with technological innovation in analytical testing
Brochure
  • Biologics
Progress your biologic with Advanced Bio comprehensive services
Insight
  • Biologics
Innovation & leadership across the advanced therapy space